Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT02105961 · COMPLETED
Trial details
- NCT number
- NCT02105961
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-24
- Primary completion
- 2017-01-16
- Enrollment
- 674
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.